Posted in Health

EMA confirms suspension or restriction of quinolone and fluoroquinolone antibiotics

The marketing authorisation of medicines containing cinoxacin, flumequine, nalidixic acid and pipemidic acid should be suspended and the use of the remaining fluoroquinolone antibiotics restricted,…

Continue Reading...